NovaBay Pharma (NBY) Reports Q3 Loss of $0.08/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
NovaBay Pharmaceuticals Reports Third Quarter 2020 Financial Results
November 12, 2020 4:05 PM ESTRevenue increased 34% versus prior year Avenova® unit sales set quarterly record Exited Q3 with $13.4 million in cash and equivalents Regained compliance with NYSE American continued-listing standards Launches CelleRx® Clinical Reset into beauty market
Conference call begins at 4:30 p.m. Eastern time today
EMERYVILLE, Calif.--(BUSINESS... More
